puls
label
cell
methionin
glucosamin
differ
time
infect
follow
sdspage
western
immunoblot
analysi
use
rabbit
antitcv
hyperimmun
serum
use
resolv
identifi
tcvinduc
intracellular
protein
viral
structur
protein
detect
radiolabel
cell
extract
hour
postinfect
well
two
possibl
nonstructur
protein
appar
molwt
predomin
nucleocapsid
protein
could
detect
cell
lysat
soon
hour
infect
initi
resolv
complex
close
migrat
speci
molwt
rang
pulsechas
immunoprecipit
experi
indic
aros
put
precursor
molwt
underw
glycosyl
proteolyt
cleavag
gp
turn
probabl
yield
gp
gp
speci
uniqu
tcv
hemagglutinin
protein
origin
primari
precursor
molwt
underw
rapid
dimer
disulfid
bond
format
glycosyl
yield
gp
peplomer
matrix
protein
shown
nglycosyl
indic
sensit
tunicamycin
tm
resist
sodium
monensin
sm
presenc
tm
protein
molwt
accumul
tcvinfect
cell
rather
peplomer
glycoprotein
matrix
protein
e
detect
unglycosyl
form
addit
tm
cultur
medium
interf
matur
progeni
viral
particl
suggest
absenc
peplom
surfac
intravacuolar
extracellular
virion
accumul
amorph
materi
found
absenc
glycosyl
inhibitor
high
yield
viru
replic
obtain
presenc
sm
even
concentr
greatli
affect
cellular
function
dea
et
al
coronaviru
virion
possess
two
three
major
envelop
glycoprotein
latter
synthes
differ
virusspecif
subgenom
rna
translat
level
membranebound
ribosom
undergo
posttransl
process
level
rough
endoplasm
reticulum
golgi
apparatu
peplomer
protein
precursor
mous
hepat
mhv
avian
infecti
bronchiti
ibv
virus
cotransl
nglycosyl
appar
molwt
polypeptid
synthes
vitro
tunicamycintr
cell
molwt
approxim
agre
molwt
polypeptid
moieti
predict
nucleotid
sequenc
gene
glycoprotein
molwt
approxim
identifi
intracellular
precursor
protein
bovin
enter
coronaviru
bcv
hemagglutin
mammalian
coronaviru
unglycosyl
precursor
yet
identifi
bcv
concomit
loss
surfac
project
viru
neither
infecti
hemagglutin
cultiv
presenc
tm
follow
glycosyl
peplomer
protein
coronavirus
undergo
proteolyt
cleavag
yield
two
subunit
molwt
proteolyt
cleavag
hostcel
depend
event
requir
activ
cellfus
activ
therefor
appear
import
determin
viral
pathogenesi
precursor
protein
bcv
hemagglutin
protein
gp
monom
gp
disulfidelink
dimer
ntermin
region
matrix
e
protein
mhv
bcv
bear
oligosaccharid
chain
lack
mannos
fucos
olink
serin
threonin
residu
unusu
featur
among
viral
glycoprotein
therefor
glycosyl
process
intracellular
precursor
depend
transfer
oligosaccharid
dolichol
phosphat
intermedi
inhibit
tunicamycin
sodium
monensin
inhibitor
golgi
function
matrix
glycoprotein
avian
infecti
bronchiti
viru
ibv
porcin
transmiss
gastroenter
viru
tgev
unlik
mhv
bcv
nlink
complex
oligosaccharid
like
found
peplomer
glycoprotein
inde
two
potenti
nglycosyl
site
avail
near
nterminu
sequenc
e
gene
virus
signific
divers
glycosyl
pattern
among
coronavirus
known
turkey
enter
coronaviru
tcv
major
etiolog
agent
epidem
diarrhea
turkey
poult
possess
hemagglutin
activ
surfac
project
two
differ
type
biochem
characterist
resembl
mammalian
hemagglutin
coronavirus
tcv
isol
also
propag
cell
establish
cell
line
origin
human
rectal
adenocarcinoma
present
studi
investig
intracellular
synthesi
posttransl
modif
viruscod
polypeptid
cultur
infect
tcv
presenc
absenc
glycosyl
inhibitor
put
intracellular
glycosyl
unglycosyl
precursor
identifi
glycoprotein
associ
type
surfac
project
matrix
protein
c
v
f
u
n
glycosyl
process
sensit
tunicamycin
resist
sodium
monensin
effect
glycosyl
inhibitor
viral
morphogenesi
confirm
electron
microscopi
tcvinfect
cell
glycosyl
matrix
protein
appar
requir
format
tcv
virion
minnesota
strain
tcv
viru
stock
obtain
propag
cell
presenc
trypsin
previous
describ
five
success
passag
viru
clone
twice
limit
dilut
method
clone
viru
passag
multipl
infect
tcid
per
cell
origin
rabbit
antitcv
hyperimmun
serum
describ
previous
analys
intracellular
synthesi
viral
polypeptid
cell
infect
multipl
tcid
given
time
indic
result
figur
legend
mainten
medium
replac
medium
without
methionin
min
methionin
starvat
cell
pulselabel
min
addit
mlflask
methioninefre
rpmi
contain
methionin
replic
cultur
chase
hour
replac
pulsemedium
complet
rpmi
contain
fb
harvest
icecold
pb
experi
tunicamycin
gg
ml
sodium
monensin
gm
use
inhibitor
ad
begin
starvat
period
present
throughout
rest
experi
pulsechas
label
intracellular
polypeptid
infect
cell
starv
methionin
label
ad
tciml
methionin
methioninefre
medium
begin
hour
pi
differ
experi
min
puls
period
cell
rins
twice
complet
rpmi
incub
medium
rain
h
harvest
cell
sheet
rins
twice
pb
scrape
icecold
lysi
buffer
ripa
made
mm
ph
mm
mm
edta
triton
sd
unit
aprotininml
pmsfml
cell
lysat
immedi
pass
time
syring
needl
heat
rain
clarifi
centrifug
x
g
store
uninfect
cell
similarli
radiolabel
mock
lysat
prepar
control
sampl
immunoprecipit
assay
perform
accord
deregt
et
al
briefli
sampl
gl
clarifi
radiolabel
cytosol
extract
cpm
mix
antitcv
serum
bound
protein
asepharos
incub
h
replica
prepar
electrophoresi
transfer
protein
separ
sdspage
nitrocellulos
sheet
tm
pore
size
schteicher
et
schill
previous
describ
satur
bovin
serum
albumin
grade
v
nitrocellulos
sheet
incub
h
room
temperatur
rabbit
hyperimmun
sera
dilut
tb
vv
tween
tbst
nitrocellulos
sheet
subsequ
wash
time
min
tbst
incub
dilut
peroxidaselabel
goat
antirabbit
igg
boehringermannheim
tbst
rain
wash
blot
develop
reaction
sigma
substrat
prepar
tb
contain
vv
methanol
sampl
mix
equal
volum
doubl
strength
sampl
buffer
without
boil
min
clarifi
x
g
min
electrophoresi
percent
sdspolyacrylamid
slab
gel
previous
describ
high
low
molecular
weight
marker
protein
marker
protein
run
gel
allow
molecular
weight
estim
viral
protein
gel
analyz
autoradiographi
fluorographi
amplifi
amersham
treatment
dri
gel
expos
kodak
xomat
rp
film
em
infect
cell
cultiv
presenc
tunicamycin
sodium
monensin
done
fixat
glutaraldehyd
follow
postfix
osmium
tetroxid
dehydr
grade
ethanol
embed
epoxi
previous
describ
thin
section
stain
leadcitr
uranyl
acet
examin
em
philip
microscop
tunicamycin
tm
sodium
monensin
sm
phenylmethylsulfonyl
fluorid
pmsf
aprotinin
purchas
boehringermannheim
canada
ltd
dorval
quebec
stock
solut
tm
sodium
monensin
prepar
dimethylsulfoxid
methanol
respect
inhibitor
also
purchas
calbiochem
la
jolta
ca
bovin
pancreat
trypsin
tpck
treat
unitsmg
purchas
sigma
chemic
co
st
loui
mo
reagent
sdspage
purchas
biorad
laboratori
richmond
ca
protein
sepharos
molecular
weight
marker
protein
purchas
pharmacia
uppsala
sweden
l
methionin
cimmol
mixtur
marker
protein
purchasesd
amersham
searl
co
oakvil
ontario
glucosamin
hydrochlorid
cimmol
purchas
icn
biochem
canada
ltd
montreal
quebec
puls
label
cell
methionin
differ
time
infect
follow
p
g
e
use
resolv
identifi
polypeptid
design
specif
tcvinfect
cell
cultur
fig
late
infect
possibl
detect
synthesi
four
major
tcvinduc
polypeptid
appar
molwt
present
mockinfect
control
cultur
lane
four
five
minor
polypeptid
also
consist
resolv
migrat
estim
molwt
respect
fig
arrowhead
minor
polypeptid
reproduc
resolv
doublet
predomin
nucleoprotein
could
detect
soon
hour
postinfect
initi
resolv
group
close
migrat
band
two
polypeptid
migrat
estim
molwt
respect
hour
four
major
tcvinduc
polypeptid
present
persist
viru
host
cell
protein
synthesi
reduc
due
extens
cytopath
chang
hour
postinfect
hour
polypeptid
appear
synthes
rel
constant
rate
without
appar
shutoff
host
cell
protein
synthesi
four
major
intracellular
polypeptid
speci
comigr
viral
polypeptid
lane
v
well
polypeptid
speci
latter
comigr
also
polypeptid
similar
molwt
also
present
mockinfect
cell
polypeptid
well
speci
close
migrat
nucleocapsid
protein
reveal
westernimmunoblot
use
antitcv
rabbit
hyperimmun
serum
fig
c
polypeptid
reveal
antiserum
may
repres
nonstructur
polypeptid
reduc
condit
fig
b
major
intracellular
polypeptid
present
replac
anoth
major
compon
molwt
approxim
intracellular
polypeptid
correspond
viral
matrix
protein
usual
resolv
doublet
investig
intracellular
process
viral
structur
protein
tcvinfect
mockinfect
cell
pulselabel
hour
infect
min
methionin
label
chase
variou
time
polypeptid
specif
tcvinfect
cell
cultur
immunoprecipit
rabbit
antitcv
hyperimmun
serum
precipit
analyz
sdspage
shown
fig
pulsechas
experi
conduct
hour
infect
permit
identif
new
immunoprecipit
protein
speci
molwt
approxim
process
major
nucleocapsid
protein
appar
hourchas
period
signific
variat
note
intens
protein
band
molwt
speci
present
first
hour
chase
period
disappear
gel
concomit
appear
weak
band
correspond
polypeptid
approxim
molwt
later
seem
convert
gp
speci
molwt
speci
present
sinc
begin
chase
period
progress
chase
give
final
gp
speci
protein
speci
also
present
begin
chase
period
increas
intens
without
appar
chang
electrophoret
mobil
molwt
speci
evid
rain
remain
detect
end
chase
period
protein
band
intensifi
infect
progress
concomit
increas
intens
gp
molwt
speci
higher
molwt
polypeptid
disappear
later
infect
process
seem
also
occur
among
lower
molwt
protein
molwt
protein
comigr
protein
present
mockinfect
cell
lysat
data
shown
appear
chase
molwt
speci
minor
band
also
appear
gel
first
hour
chase
period
process
small
matrix
glycoprotein
could
hardli
demonstr
immunoprecipit
howev
sdspage
analysi
cell
lysat
obtain
variou
chase
period
increas
intens
protein
band
note
concomit
decreas
protein
band
presum
due
glycosyl
form
fig
immunoprecipit
chase
lysat
preimmun
serum
neg
immunoprecipit
uninfect
lysat
specif
hyperimmun
serum
data
shown
determin
natur
glycosid
bond
present
tcv
glycoprotein
infect
mockinfect
cell
maintain
media
supplement
either
tunicamycin
tm
sodium
monensin
sm
pulselabel
methionin
glucosamin
follow
effect
inhibitor
synthesi
glycosyl
tcvinduc
intracellular
protein
cytopath
chang
polycaryocytosi
observ
tcvinfect
cell
cultur
grown
presenc
tgml
tm
contrast
addit
tm
sodium
monensin
interfer
tunicamycin
concentr
lagml
slightli
decreas
overal
intracellular
protein
synthesi
suggest
intens
band
methioninelabel
protein
resolv
sdspage
cell
lysat
polypeptid
correspond
tcv
peplomer
glycoprotein
show
drastic
decreas
appar
molecular
weight
yield
polypeptid
speci
fig
arrowhead
new
intracellular
polypeptid
also
resolv
western
immunoblot
fig
b
radioimmunoprecipit
experi
use
antitcv
hyperimmun
serum
methionin
glucosamin
label
confirm
absenc
peplomer
glycoprotein
tmtreat
cell
wherea
rel
amount
unglycosyl
high
molwt
polypeptid
speci
increas
fig
lane
major
nonglycosyl
polypeptid
molwt
also
reveal
presenc
tm
contrast
type
surfac
glycoprotein
gp
immunoprecipit
extract
smtreat
tcvinfect
cell
strongli
label
glucosamin
fig
lane
major
polypeptid
approxim
molwt
also
immunoprecipit
treatment
sm
appear
slightli
label
glucosamin
fig
lane
glycosyl
matrix
protein
tcv
also
affect
tm
neither
major
molwt
speci
could
immunoprecipit
tm
treatment
fig
contrast
protein
speci
identifi
immunoprecipit
extract
untreat
smtreat
tcvinfect
cell
fig
b
matur
tcv
absenc
presenc
glycosyl
inhibitor
follow
sequenti
analysi
em
ultrathin
section
tcvinfect
cell
electron
microscop
examin
neg
stain
untreat
tcvinfect
cell
hour
inocul
reveal
bud
coronaviru
particl
intracytoplasm
membran
accumul
lumen
smoothwal
vesicl
fig
progeni
viral
particl
shown
outer
surfac
infect
cell
none
observ
bud
plasma
membran
intracellular
extracellular
viral
particl
spheric
shape
electronluc
center
possess
larg
bulbou
surfac
project
fig
b
format
ofvirion
inhibit
ggml
tm
fig
complet
virion
observ
dilat
cytoplasm
vacuol
also
import
accumul
amorph
materi
suggest
least
partial
interfer
viral
assembl
fig
virion
present
cytoplasm
vacuol
migrat
cell
surfac
appar
lack
characterist
larg
peplom
coronavirus
fig
b
virion
releas
tmtreat
cell
usual
none
adsorb
plasma
membran
addit
sm
medium
tcvinfect
cell
cultur
interfer
normal
matur
viru
fig
larg
number
progeni
viral
particl
could
observ
cytosol
even
sm
concentr
gmml
howev
high
concentr
sm
seem
toxic
cell
suggest
intens
vacuolis
fig
b
viral
particl
accumul
lumen
smoothwal
vesicl
fig
n
u
e
r
u
viral
particl
observ
intercellular
space
n
adsorb
plasma
membran
virion
possess
characterist
surfac
peplom
long
tubul
n
diamet
accumul
dilat
cysterna
cytoplasm
vacuol
fig
b
previou
studi
structur
protein
tcv
virion
produc
cell
cultur
ovo
reveal
polypeptid
pattern
describ
far
virus
belong
subgroup
mammalian
hemagglutin
coronavirus
addit
peplomer
matrix
glycoprotein
tcv
virion
contain
envelop
glycoprotein
molwt
behav
disulfidelink
dimer
subunit
associ
hemagglutinin
accompani
paper
paper
describ
identif
virusinduc
intracellular
polypeptid
tcvinfect
cell
kinet
synthesi
posttransl
process
presenc
glycosyl
inhibitor
signific
respect
product
matur
virion
found
tcv
modest
inhibitori
effect
cell
protein
synthesi
make
analysi
virusspecif
protein
difficult
nevertheless
new
intracellular
protein
speci
could
detect
soon
h
postinfect
either
sdspage
analysi
pulselabel
tcvinfect
cell
extract
westernimmunoblot
use
antitcv
hyperimmun
serum
produc
eggadapt
minnesota
strain
tcv
structur
protein
detect
h
postinfect
agreement
onestep
growth
curv
determin
previou
studi
replic
cycl
coronavirus
least
polypeptid
immunoprecipit
lysat
tcvinfect
cell
six
polypeptid
approxim
molwt
comigr
virion
protein
although
definit
relationship
could
establish
among
variou
intracellular
polypeptid
pulsechas
experi
analysi
infect
cell
extract
cultiv
presenc
glycosyl
inhibitor
suggest
product
correspond
intracellular
precursor
cleavag
product
aggreg
form
structur
glycoprotein
process
nucleocapsid
n
protein
appar
two
addit
virusspecif
bind
protein
migrat
slightli
ahead
n
also
identifi
mhv
ibv
two
speci
react
monospecif
antin
antibodi
vitro
translat
studi
n
gene
shown
may
correspond
degrad
product
n
k
polypeptid
speci
present
tcvinfect
cell
lysat
appar
virusinduc
host
cell
nonstructur
protein
reveal
westernimmunoblot
nonstructur
protein
similar
molwt
also
detect
infect
cel
lysat
protein
molwt
also
obtain
follow
cellfre
translat
virion
genom
rna
sinc
basic
protein
abund
infect
cell
late
infect
suggest
may
involv
process
genom
subgenom
rna
pulsechas
studi
also
reveal
tcv
peplomer
glycoprotein
undergo
consider
posttransl
chang
incorpor
virion
first
glycosyl
primari
translat
product
gene
may
result
synthesi
speci
glycosyl
yield
gp
subsequ
proteolyt
cleavag
gp
yield
gp
gp
demonstr
accompani
paper
appear
occur
quit
effici
two
speci
predomin
speci
precipit
tcvinfect
cell
extract
pattern
process
similar
pattern
propos
bcv
mhv
ibv
primari
glycosyl
precursor
appar
molwt
also
identifi
bcv
use
monoclon
antibodi
case
tcv
proteolyt
cleavag
probabl
occur
also
prior
final
glycosyl
step
molwt
nonglycosyl
polypeptid
reveal
immunoprecipit
prior
appear
gp
appar
chase
give
tcv
virion
gp
whether
two
intracetlular
polypeptid
fact
relat
remain
demonstr
may
possibl
certain
amount
primari
apoprotein
cleav
glycosyl
give
final
gp
recent
studi
intracellular
process
measl
viru
f
ha
protein
demonstr
glycosyl
essenti
posttransl
proteolyt
cleavag
proceed
similarli
result
obtain
coronaviru
suggest
proteolyt
cleavag
posttransl
event
occur
assembl
virion
process
protein
golgi
apparatu
tcv
gp
gp
speci
also
demonstr
treatment
monensin
inhibitor
golgi
function
suggest
first
glycosyl
acquir
rer
may
suffici
protein
may
also
repres
host
cell
compon
similar
molwt
group
resid
protein
er
identifi
put
receptor
carrier
involv
rergolgi
transloc
step
glucoseregul
protein
exampl
identifi
lumen
er
larg
number
differ
type
mammalian
cell
recent
demonstr
unassembl
incorrectli
assembl
ha
protein
influenza
viru
prevent
leav
er
complex
cellular
protein
approxim
molwt
resid
lumen
er
hostcel
protein
similar
molwt
also
coprecipit
lysat
measl
virusinfect
tmtreat
cell
propolypeptid
primarytransl
product
approxim
molwt
predict
amino
acid
sequenc
determin
sequenc
analysi
gene
encod
ibv
mhv
nonglycosyl
polypeptid
appar
molwt
immunoprecipit
extract
tcvinfect
tmtreat
cell
new
intracellular
polypeptid
also
identifi
westernimmunoblot
although
definit
precursorfin
product
relationship
demonstr
e
latter
synthes
presenc
tm
confirm
radiolabel
glucosamin
em
surfac
glycoprotein
tcv
virion
thu
possess
nlink
oligosaccharid
observ
nonglycosyl
polypeptid
detect
presenc
glycosyl
inhibitor
indic
glycosyl
initi
cotransl
level
typic
nglycosid
linkag
accumul
amorph
materi
cysterna
tcvinfect
tmtreat
cell
may
result
rapid
degrad
put
nonglycosyl
precursor
monensin
shown
produc
intra
golgi
blockad
number
secretori
protein
collaps
hydrogen
ion
gradient
across
cellular
membran
thu
block
glycosyl
nglycosyl
occur
rer
speci
heavili
label
glucosamin
presenc
monensin
support
result
obtain
tm
unglycosyl
molwt
protein
speci
immunoprecipit
extract
tcvinfect
cell
virion
molwt
glycoprotein
appear
differ
form
viral
protein
nonglycosyl
may
correspond
precursor
protein
undergo
glycosyl
yield
speci
rapid
dimer
disulfid
bond
yield
gp
suggest
electrophoresi
presenc
glycosyl
step
would
result
final
protein
describ
bcv
fact
e
detect
lysat
methionin
label
tcvinfect
tmtreat
cell
suggest
nlink
glycosyl
absenc
gel
molwt
speci
probabl
correspond
aggreg
form
presenc
lysat
tcvinfect
smtreat
cell
support
notion
respect
tcv
differ
virus
subgroup
mammalian
hemagglutin
coronavirus
resembl
ibv
wherea
glycosyl
glycoprotein
nglycosid
linkag
gener
initi
cotransl
level
glycosyl
e
tcv
appear
exclus
posttransl
event
suggest
observ
apoprotein
precursor
e
present
tcvinfect
cell
prior
tcv
ibv
e
therefor
constitut
exampl
membran
glycoprotein
target
er
subsequ
direct
along
secretori
pathway
previous
report
ibv
mhv
e
appear
glycoprotein
requir
format
tcv
virion
glycosyl
appar
essenti
arrest
viru
bud
demonstr
mhvinfect
cell
cultiv
presenc
monensin
demonstr
tcvinfect
cell
presenc
tm
strengthen
notion
glycosyl
e
necessari
viru
bud
